nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—MMP9—amb2 Integrin signaling—MST1—sclerosing cholangitis	0.0299	0.0364	CbGpPWpGaD
Minocycline—CYCS—Intrinsic Pathway for Apoptosis—BCL2L11—sclerosing cholangitis	0.0293	0.0357	CbGpPWpGaD
Minocycline—CASP1—Apoptosis—TNFRSF25—sclerosing cholangitis	0.0288	0.0351	CbGpPWpGaD
Minocycline—CASP1—Apoptosis Modulation and Signaling—TNFRSF25—sclerosing cholangitis	0.027	0.0329	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—TNFRSF25—sclerosing cholangitis	0.0246	0.03	CbGpPWpGaD
Minocycline—VEGFA—NOTCH1 regulation of human endothelial cell calcification—ALPL—sclerosing cholangitis	0.0239	0.0292	CbGpPWpGaD
Minocycline—CASP3—Intrinsic Pathway for Apoptosis—BCL2L11—sclerosing cholangitis	0.0236	0.0288	CbGpPWpGaD
Minocycline—VEGFA—miR-148a/miR-31/FIH1/HIF1α-Notch signaling in glioblastoma —HIF1A—sclerosing cholangitis	0.0235	0.0286	CbGpPWpGaD
Minocycline—CYCS—Apoptosis Modulation and Signaling—TNFRSF25—sclerosing cholangitis	0.0231	0.0282	CbGpPWpGaD
Minocycline—CYCS—pancreas—sclerosing cholangitis	0.0217	0.121	CbGeAlD
Minocycline—CASP3—Apoptosis—TNFRSF25—sclerosing cholangitis	0.0199	0.0242	CbGpPWpGaD
Minocycline—VEGFA—Regulation of gene expression by Hypoxia-inducible Factor—HIF1A—sclerosing cholangitis	0.0192	0.0234	CbGpPWpGaD
Minocycline—CASP3—Apoptosis Modulation and Signaling—TNFRSF25—sclerosing cholangitis	0.0186	0.0227	CbGpPWpGaD
Minocycline—CASP3—pancreas—sclerosing cholangitis	0.0186	0.104	CbGeAlD
Minocycline—CYCS—p75(NTR)-mediated signaling—BCL2L11—sclerosing cholangitis	0.0182	0.0222	CbGpPWpGaD
Minocycline—CASP1—Apoptosis—BCL2L11—sclerosing cholangitis	0.0182	0.0221	CbGpPWpGaD
Minocycline—ALOX5—Synthesis of Leukotrienes (LT) and Eoxins (EX)—GGT1—sclerosing cholangitis	0.0177	0.0216	CbGpPWpGaD
Minocycline—CASP1—Apoptosis Modulation and Signaling—BCL2L11—sclerosing cholangitis	0.017	0.0208	CbGpPWpGaD
Minocycline—CYCS—AGE/RAGE pathway—ALPL—sclerosing cholangitis	0.0166	0.0203	CbGpPWpGaD
Minocycline—CASP3—Cell death signalling via NRAGE, NRIF and NADE—BCL2L11—sclerosing cholangitis	0.0162	0.0197	CbGpPWpGaD
Minocycline—ALOX5—Eicosanoid Synthesis—GGT1—sclerosing cholangitis	0.0159	0.0194	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—BCL2L11—sclerosing cholangitis	0.0155	0.0189	CbGpPWpGaD
Minocycline—IL1B—pancreas—sclerosing cholangitis	0.0149	0.0828	CbGeAlD
Minocycline—CASP3—p75(NTR)-mediated signaling—BCL2L11—sclerosing cholangitis	0.0147	0.0179	CbGpPWpGaD
Minocycline—VEGFA—pancreas—sclerosing cholangitis	0.0146	0.0814	CbGeAlD
Minocycline—CYCS—Apoptosis Modulation and Signaling—BCL2L11—sclerosing cholangitis	0.0146	0.0178	CbGpPWpGaD
Minocycline—CASP1—liver—sclerosing cholangitis	0.0144	0.0799	CbGeAlD
Minocycline—CYCS—liver—sclerosing cholangitis	0.0138	0.0769	CbGeAlD
Minocycline—CASP3—AGE/RAGE pathway—ALPL—sclerosing cholangitis	0.0134	0.0163	CbGpPWpGaD
Minocycline—CASP3—p75 NTR receptor-mediated signalling—BCL2L11—sclerosing cholangitis	0.0128	0.0156	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—BCL2L11—sclerosing cholangitis	0.0125	0.0153	CbGpPWpGaD
Minocycline—MMP9—pancreas—sclerosing cholangitis	0.0124	0.069	CbGeAlD
Minocycline—CASP3—liver—sclerosing cholangitis	0.0119	0.0659	CbGeAlD
Minocycline—CASP3—Apoptosis Modulation and Signaling—BCL2L11—sclerosing cholangitis	0.0118	0.0143	CbGpPWpGaD
Minocycline—CASP3—Corticotropin-releasing hormone—TCF4—sclerosing cholangitis	0.0112	0.0137	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.0103	0.0126	CbGpPWpGaD
Minocycline—MMP9—Angiogenesis—HIF1A—sclerosing cholangitis	0.0101	0.0123	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—BCL2L11—sclerosing cholangitis	0.0101	0.0123	CbGpPWpGaD
Minocycline—ALOX5—pancreas—sclerosing cholangitis	0.0098	0.0545	CbGeAlD
Minocycline—MMP9—Endochondral Ossification—ALPL—sclerosing cholangitis	0.00954	0.0116	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—BCL2L11—sclerosing cholangitis	0.00951	0.0116	CbGpPWpGaD
Minocycline—IL1B—liver—sclerosing cholangitis	0.00947	0.0527	CbGeAlD
Minocycline—VEGFA—liver—sclerosing cholangitis	0.00931	0.0518	CbGeAlD
Minocycline—MMP9—AGE/RAGE pathway—ALPL—sclerosing cholangitis	0.00931	0.0113	CbGpPWpGaD
Minocycline—ALOX5—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00886	0.0108	CbGpPWpGaD
Minocycline—VEGFA—Angiogenesis—HIF1A—sclerosing cholangitis	0.00875	0.0107	CbGpPWpGaD
Minocycline—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—TCF4—sclerosing cholangitis	0.00869	0.0106	CbGpPWpGaD
Minocycline—VEGFA—Cellular response to hypoxia—HIF1A—sclerosing cholangitis	0.00847	0.0103	CbGpPWpGaD
Minocycline—IL1B—Type II interferon signaling (IFNG)—NOS2—sclerosing cholangitis	0.00846	0.0103	CbGpPWpGaD
Minocycline—IL1B—IL23-mediated signaling events—NOS2—sclerosing cholangitis	0.00846	0.0103	CbGpPWpGaD
Minocycline—VEGFA—Endochondral Ossification—ALPL—sclerosing cholangitis	0.00828	0.0101	CbGpPWpGaD
Minocycline—CASP3—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.00814	0.00993	CbGpPWpGaD
Minocycline—CYCS—AGE/RAGE pathway—HIF1A—sclerosing cholangitis	0.00801	0.00977	CbGpPWpGaD
Minocycline—MMP9—liver—sclerosing cholangitis	0.00789	0.0439	CbGeAlD
Minocycline—VEGFA—Alpha9 beta1 integrin signaling events—NOS2—sclerosing cholangitis	0.00771	0.0094	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—BCL2L11—sclerosing cholangitis	0.00768	0.00936	CbGpPWpGaD
Minocycline—VEGFA—VEGFR1 specific signals—HIF1A—sclerosing cholangitis	0.00752	0.00917	CbGpPWpGaD
Minocycline—SLC22A11—liver—sclerosing cholangitis	0.00748	0.0416	CbGeAlD
Minocycline—SLC22A7—liver—sclerosing cholangitis	0.0073	0.0406	CbGeAlD
Minocycline—CYCS—AGE/RAGE pathway—NOS2—sclerosing cholangitis	0.00729	0.00889	CbGpPWpGaD
Minocycline—CASP3—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.00718	0.00876	CbGpPWpGaD
Minocycline—IL1B—Selenium Micronutrient Network—GGT1—sclerosing cholangitis	0.00668	0.00815	CbGpPWpGaD
Minocycline—CASP3—Oncostatin M Signaling Pathway—HIF1A—sclerosing cholangitis	0.00655	0.00798	CbGpPWpGaD
Minocycline—CASP3—AGE/RAGE pathway—HIF1A—sclerosing cholangitis	0.00647	0.00788	CbGpPWpGaD
Minocycline—ALOX5—liver—sclerosing cholangitis	0.00624	0.0347	CbGeAlD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00621	0.00757	CbGpPWpGaD
Minocycline—CYCS—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00596	0.00727	CbGpPWpGaD
Minocycline—CASP3—AGE/RAGE pathway—NOS2—sclerosing cholangitis	0.00588	0.00717	CbGpPWpGaD
Minocycline—IL1B—IL12-mediated signaling events—NOS2—sclerosing cholangitis	0.00575	0.007	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—GGT1—sclerosing cholangitis	0.00564	0.00687	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.0047	0.00573	CbGpPWpGaD
Minocycline—MMP9—AGE/RAGE pathway—HIF1A—sclerosing cholangitis	0.00449	0.00547	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—HIF1A—sclerosing cholangitis	0.00428	0.00522	CbGpPWpGaD
Minocycline—MMP9—AGE/RAGE pathway—NOS2—sclerosing cholangitis	0.00408	0.00498	CbGpPWpGaD
Minocycline—VEGFA—Oncostatin M Signaling Pathway—HIF1A—sclerosing cholangitis	0.00394	0.00481	CbGpPWpGaD
Minocycline—VEGFA—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.0039	0.00475	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—NOS2—sclerosing cholangitis	0.0037	0.00451	CbGpPWpGaD
Minocycline—VEGFA—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.00354	0.00432	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—NOS2—sclerosing cholangitis	0.00334	0.00408	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—HIF1A—sclerosing cholangitis	0.00325	0.00396	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00309	0.00377	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.00309	0.00377	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—HIF1A—sclerosing cholangitis	0.00294	0.00359	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00281	0.00342	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—HIF1A—sclerosing cholangitis	0.00264	0.00322	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—NOS2—sclerosing cholangitis	0.00257	0.00313	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00236	0.00288	CbGpPWpGaD
Minocycline—CYCS—Metabolism—ABCB4—sclerosing cholangitis	0.00223	0.00272	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TCF4—sclerosing cholangitis	0.00203	0.00247	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00197	0.0024	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—HIF1A—sclerosing cholangitis	0.00196	0.00239	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TCF4—sclerosing cholangitis	0.00176	0.00214	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ABCB4—sclerosing cholangitis	0.00138	0.00168	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—HIF1A—sclerosing cholangitis	0.00129	0.00157	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.00127	0.00154	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GOT2—sclerosing cholangitis	0.00106	0.00129	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.00101	0.00123	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GOT1—sclerosing cholangitis	0.000915	0.00112	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GGT1—sclerosing cholangitis	0.000915	0.00112	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000701	0.000855	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—NOS2—sclerosing cholangitis	0.000695	0.000847	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GOT2—sclerosing cholangitis	0.000653	0.000797	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000609	0.000742	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GGT1—sclerosing cholangitis	0.000564	0.000688	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GOT1—sclerosing cholangitis	0.000564	0.000688	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HIF1A—sclerosing cholangitis	0.00043	0.000524	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000298	0.000364	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000259	0.000316	CbGpPWpGaD
